MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common vitamin boost immunotherapy for melanoma?
Disease control OngoingThis early-phase trial is testing whether taking high-dose vitamin B5 (pantothenic acid) can help standard immunotherapy work better for people with advanced melanoma that cannot be surgically removed. The study includes 12 participants who have not had prior treatment for their …
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a 4-Week drug course keep melanoma from coming back?
Disease control OngoingThis study looked at whether giving high-dose interferon alfa-2b for four weeks after melanoma surgery helps keep the cancer from returning. About 1,150 people with stage II or III melanoma that was completely removed took part. Half got the drug and half were simply watched. The…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Smart drug schedule may improve melanoma treatment
Disease control OngoingThis early-phase study tested a new way of giving three drugs (encorafenib, binimetinib, and nivolumab) to people with advanced BRAF-mutant melanoma. Instead of taking the drugs every day, participants followed an on/off schedule to see if it could control the cancer while reduci…
Matched conditions: MELANOMA (SKIN)
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
DNA vaccines aim to supercharge immune therapy against skin cancer
Disease control OngoingThis phase 2 trial is testing two experimental DNA vaccines, SCIB1 and iSCIB1+, in combination with standard immunotherapy drugs for people with advanced melanoma that cannot be removed by surgery. The study involves 173 participants and aims to see if adding these vaccines is sa…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC